Mosunetuzumab (BCT-4465A) is a humanized antibody based on immunoglobulin G1 that targets CD20 (B cells) and CD3 (T cells).

Skp2 inhibitor 1 is a Skp2-Cks1 interaction inhibitor (IC50: 2.8μM) with antitumor activity and can be used to study cancer.

Monoethyl phthalate, a metabolite of diethyl phthalate, serves as a urinary biomarker for phthalate exposure and indicates potential risks of thyroid cancer and benign nodules.